🛡️ CVE-2026-31070
Description
The LalanaChami Pharmacy Management System (commit 5c3d028) allows unauthenticated remote attackers to escalate privileges by self-assigning an administrative role during registration. The /api/user/signup endpoint fails to validate the role parameter in the request body
How this vulnerability can be exploited
This issue can be reached over the network, attack complexity is low, an attacker needs no privileges on the target. No user interaction is required. The scope is unchanged, so the impact stays within the vulnerable component. Rated impact: confidentiality high, integrity high, availability high.
Weakness class
CVE-2026-31070 is classified as CWE-269: Improper Privilege Management. Privileges are assigned, dropped or restored incorrectly, leaving an actor with more access than intended.
Affected software
CVE-2026-31070 is recorded against 1 package.
- unknown
Timeline and source
Published on 19 May 2026 and last revised on 24 July 2026. No public exploit is currently recorded for this entry. Record sourced from NVD.
References
Details
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Affected Packages
| Software | From version | Fixed in |
|---|---|---|
| unknown | — | — |
References
Similar Threats
- Unknown CVE-2022-0003
- Unknown CVE-2022-0303
- High CVE-2022-1206
- Unknown CVE-2022-0931
- Unknown CVE-2022-0094
Exploit Protection
Are you running the affected software?
CVE-2026-31070 carries CVSS 9.8 Critical rating. BotEraser checks your installation against this and other known CVE records, and blocks IPs associated with exploit activity.
Check My Site For CVE-2026-31070 →No credit card required · Results in minutes
ⓘ Data Notice: The information presented above has been compiled from publicly available internet sources. Boteraser aggregates this data solely for informational purposes and does not independently classify, evaluate, or endorse any findings about the vulnerabilities listed. The accuracy and completeness of this information is the sole responsibility of the original publishers. Boteraser and its operators accept no liability for any decisions made based on this data.